HALO
68.03 USD
+0.51%
Today
+1.00%
1D
Market is closed
Sun
Closed
Mon
4:30 PM ~ 11:00 PM
Tue
4:30 PM ~ 11:00 PM
Wed
4:30 PM ~ 11:00 PM
Thu
4:30 PM ~ 11:00 PM
Fri
4:30 PM ~ 11:00 PM
Sat
Closed
Information
Name
Halozyme Therapeutics Leveraged
Currency
USD
Standard Leverage
1X
Enhanced Leverage
3X
Overnight Fees Buy
-0.0191%
Overnight Fees Sell
0.0024%
Market Cap
8.03B
Avg Daily Volume
1.39M
52 Week High
82.22 USD
52 Week Low
47.5 USD
Trading Hours
See hours
Overnight Fees Calculator
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01910% | $(0.191) |
| SELLS | 0.00240% | $0.024 |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Business Summary
Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. It offers Hylenex recombinant, a formulation of rHuPH20 that facilitates subcutaneous (SC) administration to enhance the dispersion and absorption of other injected drugs in SC urography and to enhance resorption of radiopaque agents; and XYOSTED, an injection for SC administration of testosterone replacement therapy. The company also provides Herceptin (trastuzumab) under the brand name Herceptin Hylecta; and Phesgo to treat breast cancer; Mabthera SC for chronic lymphocytic leukemia treatment; Tecentriq SC for IV infusion; Ocrevus SC for multiple sclerosis; HYQVIA to treat primary immunodeficiency disorders; DARZALEX to treat amyloidosis, and smoldering and multiple myeloma; epinephrine Injection to treat allergic reactions; nivolumab and relatlimab to treat metastatic or unresectable melanoma; teriparatide injections; ARGX-113; and ARGX-117 to treat severe autoimmune diseases in multifocal motor neuropathy. It has collaborations and licensing agreements with F. Hoffmann-La Roche, Ltd. and Hoffmann-La Roche, Inc.; Takeda Pharmaceuticals International AG and Baxalta US Inc.; Pfizer Inc.; Janssen Biotech, Inc.; AbbVie, Inc.; Eli Lilly and Company; Bristol Myers Squibb Company; argenx BVBA; ViiV Healthcare; Chugai Pharmaceutical Co., Ltd.; Acumen Pharmaceuticals, Inc.; Merus N.V.; and Skye Bioscience, Inc. The company was founded in 1998 and is headquartered in San Diego, California.
Top News
Arista
+1.12%
Broadcom
+4.79%
BakerHghs
-0.92%
Caseys
-2.66%
CFIndustries
+1.73%
CVSCare
+0.82%
Chevron
-0.53%
Elevance-Health-Inc
-2.02%
EnergyTransfer
+0.63%
Flagstar.Financial
-0.78%
GeneralDyn
-2.65%
Halozyme
+1.00%
Humana
-2.52%
Intel
+1.02%
Levi.Strauss
+0.00%
Cheniere
-0.08%
MercadoLbr
-1.16%
Neurocrine
-2.14%
OldDominion
-0.58%
Oneok
+0.24%
VirginGalactic
+1.69%
UnitedHlt
-0.66%
Valero
+1.57%
Williams
-0.12%
ExxonMobil
-1.24%
BUZZ-U.S. STOCKS ON THE MOVE-UnitedHealth, Intel, Apple
reuters.com
3d ago
Arista
+1.12%
Broadcom
+4.79%
BakerHghs
-0.92%
Caseys
-2.66%
CFIndustries
+1.73%
CVSCare
+0.82%
Elevance-Health-Inc
-2.02%
GeneralDyn
-2.65%
Halozyme
+1.00%
Humana
-2.52%
MercadoLbr
-1.16%
Neurocrine
-2.14%
OldDominion
-0.58%
VirginGalactic
+1.69%
UnitedHlt
-0.66%
BUZZ-U.S. STOCKS ON THE MOVE -Health insurers, Arista, Savara
reuters.com
3d ago
News by Dow Jones Newswires on TradingView, 2026-03-12
tradingview.com
0mo ago
Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
